Baxter Healthcare Corporation recalls Doxil (doxorubicin hydrochloride liposome injection) 50 mg in 25 mL (2 mg/mL), Single-Dose Vial, Rx only, Manufactured f

Recalled October 25, 2023 · FDA recall D-0048-2024 · Baxter Healthcare

Hazard

CGMP Deviations: Product was exposed to temperatures exceeding the labeled storage conditions during transportation were released by mistake. · FDA Class II

Units

472 vials

Sold at

Nationwide in the USA

Description

CGMP Deviations: Product was exposed to temperatures exceeding the labeled storage conditions during transportation were released by mistake.

Product

Doxil (doxorubicin hydrochloride liposome injection) 50 mg in 25 mL (2 mg/mL), Single-Dose Vial, Rx only, Manufactured for: Baxter Healthcare Corporation, Deerfield, IL 60015. NDC 0338-0067-01

Manufacturer(s)

Baxter Healthcare Corporation

Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →